Hydroquinidine
-
Hydroquinidine
structure -
-
CAS No:
1435-55-8
-
Formula:
C20H26N2O2
-
Chemical Name:
Hydroquinidine
-
Synonyms:
Cinchonan-9-ol,10,11-dihydro-6′-methoxy-,(9S)-;Hydroquinidine;(9S)-10,11-Dihydro-6′-methoxycinchonan-9-ol;Dihydroquinidine;Hydroconquinine;10,11-Dihydroquinidine;(+)-Hydroquinidine;1415-00-5;900786-91-6;904813-09-8;1089762-75-3;1195456-48-4;2176466-42-3
-
Categories:
Active Pharmaceutical Ingredients > Circulatory System Drugs
-
CAS No:
Description
Solid
Hydroquinidine is under investigation in clinical trial NCT00927732 (Hydroquinidine Versus Placebo in Patients With Brugada Syndrome).
Hydroquinidine Basic Attributes
326.43
326.43
215-862-5
8P68XPY4HG
C - Cardiovascular system
29339900
Characteristics
45.6
1.1117 (rough estimate)
168.5 °C
464.47°C (rough estimate)
255.2±24.6 °C
1.6800 (estimate)
chloroform: 0.1 g/mL, clear
226 º (C=2 IN ETOH)
176.7 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Safety Information
III
6.1(b)
1544
3
20/21/22
36/37-36
MX3016000
Xn
P280
H302 + H312 + H332
|Warning|H302 (97.5%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P312, P322, P330, P363, and P501|Aggregated GHS information provided by 40 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug Information
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)|Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
dihydroquinidine
Computed Properties
Molecular Weight:326.4
XLogP3:3.1
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:4
Exact Mass:326.199428076
Monoisotopic Mass:326.199428076
Topological Polar Surface Area:45.6
Heavy Atom Count:24
Complexity:432
Defined Atom Stereocenter Count:4
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of Hydroquinidine
-
CN
1 YR
Business licensed Certified factoryManufactory Supplier of Ginsenoside Rb1,Ginsenoside Rg1,Ginsenoside Re,Ginsenoside CK,Ginsenoside Rg2,Ginsenoside Rg5,Ginsenoside Rg5,Ginsenoside Rh2,Protopanaxatriol,Epmedin C,Icariin,Icaritin,Baohuoside I,Total Ginsenosides,Total Ginsenosides from Ginseng Stems And Leaves,Oridonin,Oleuropein,Curcumin,(20)-Ginsenoside Rg3,(20)-ProtopanaxadiolInquiryUnit Price: $4300-4500 /MT FOBCAS No.: 1435-55-8Grade: Industrial GradeContent: 98%
Learn More Other Chemicals
-
Hydroquinidine hydrochloride
1476-98-8
-
Dronedarone
141626-36-0
-
Zofenopril calcium
81938-43-4
-
3-Bromo-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one Formula
86499-96-9
-
Tirofiban hydrochloride monohydrate Formula
150915-40-5
-
Saxagliptin Formula
361442-04-8
-
Dapoxetine Structure
119356-77-3
-
Fasudil Structure
103745-39-7
-
What is 3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, 3-methyl 5-[(1-oxobutoxy)methyl] ester
167221-71-8
-
What is 3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)]][4-[trimethylsilyl]-oxy]phenyl]methyl]-1-oxo-5-[(trimethylsily)-oxy]pentyl]-4-phenyl-(4S)-2-oxazolidinone
272778-12-8